Immunic, Inc. (IMUX)
16.50
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
16.50
0.00 (0.00%)
After-Hours: 20:00
Immunic Shareholders Equity (Quarterly) : 127.58M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.58M |
| March 31, 2026 | 151.23M |
| December 31, 2025 | -6.673M |
| September 30, 2025 | 10.50M |
| June 30, 2025 | 33.91M |
| March 31, 2025 | -5.287M |
| December 31, 2024 | 18.43M |
| September 30, 2024 | 41.22M |
| June 30, 2024 | 63.57M |
| March 31, 2024 | 83.58M |
| December 31, 2023 | 28.93M |
| September 30, 2023 | 48.41M |
| June 30, 2023 | 69.28M |
| March 31, 2023 | 91.22M |
| December 31, 2022 | 113.68M |
| September 30, 2022 | 108.81M |
| June 30, 2022 | 127.85M |
| March 31, 2022 | 137.96M |
| December 31, 2021 | 127.12M |
| September 30, 2021 | 145.46M |
| June 30, 2021 | 120.74M |
| March 31, 2021 | 137.45M |
| December 31, 2020 | 158.78M |
| September 30, 2020 | 162.88M |
| June 30, 2020 | 78.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.49M |
| December 31, 2019 | 58.36M |
| September 30, 2019 | 60.53M |
| June 30, 2019 | 69.41M |
| March 31, 2019 | 9.049M |
| December 31, 2018 | -25.74M |
| September 30, 2018 | 14.25M |
| June 30, 2018 | 26.45M |
| March 31, 2018 | 37.30M |
| December 31, 2017 | 50.04M |
| September 30, 2017 | 62.08M |
| June 30, 2017 | 73.34M |
| March 31, 2017 | 84.43M |
| December 31, 2016 | 58.45M |
| September 30, 2016 | 67.76M |
| June 30, 2016 | 74.15M |
| March 31, 2016 | 78.05M |
| December 31, 2015 | 82.32M |
| September 30, 2015 | 58.68M |
| June 30, 2015 | 69.74M |
| March 31, 2015 | 83.78M |
| December 31, 2014 | 97.56M |
| September 30, 2014 | 77.05M |
| June 30, 2014 | 89.16M |
| March 31, 2014 | 46.70M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Sionna Therapeutics, Inc. | 265.78M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.17M |
| Total Liabilities (Quarterly) | 31.59M |
| Debt to Equity Ratio | 0.0044 |
| Current Ratio | 5.049 |
| Net Debt Paydown Yield | 0.04% |